CTRI/2023/07/055651尚未招募Unknown
A randomised,prospective and unblinded manner clinical trial to compare the effect of inhaled budesonide suspension with budesonide nebuliseron severity of postoperative sorethroat subsequent to endotracheal intubation
Pt B D Sharma University of Health Sciences PGIMS, Rohtak, Haryana0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients belonging to ASA 1-2 with MPG 1-2 undergoing surgery under general anaesthesia
排除标准
- •Patients with anticipated difficult airway, history of allergy to test drug,active preoperative sore throat,analgesics and corticosteroids in treatment regime,history of fluid retention, history of delayed wound healing, history of glucose intolerance,laparoscopic surgeries ,duration of surgery < 60min or >180min, refusal to participate in the study will be excluded from the study
研究者
相似试验
尚未招募
不适用
Prospective, randomized, subject single-blind, double-arm study to evaluate the outcome of ADM without basement membrane in prosthetic breast reconstructioKCT0005852Asan Medical Center60
进行中（未招募）
不适用
An randomized, controlled, investigator-blinded, prospective, mono-centre study to evaluate the efficacy of fosfomycin versus meropenem in patients with complicated urinary tract infections - urosepsis/fosfo vs. meropenemThis study will primarily address the question of the efficacy of intravenous fosfomycin 4 g b.i.d. in the therapy of patients presenting with complicated urinary tract infection. These data will be compared to meropenem administered intravenously at a dose of 2 g b.i.d.MedDRA version: 9.1Level: LLTClassification code 10046571Term: Urinary tract infectionEUCTR2007-005112-37-ATMedizinische Universität Wien, Abteilung für Interne Medizin I240
进行中（未招募）
1 期
Safety, tolerability and efficacy study of CLL442 in patients with Cutaneous Squamous Cell Carcinoma in situ (SCCis).EUCTR2017-003495-31-BEovartis Pharma AG40
进行中（未招募）
1 期
Study of LIK066 in overweight and obese women with polycystic ovary syndromepolycystic ovary syndromeMedDRA version: 20.0Level: LLTClassification code 10036050Term: Polycystic ovarySystem Organ Class: 100000004872EUCTR2017-001373-16-DEovartis Pharma AG29
进行中（未招募）
1 期
Study of safety, tolerability, pharmacokinetics and pharmacodynamics of QBW251 in subjects with bronchiectasisMedDRA version: 23.0Level: LLTClassification code 10083611Term: Non-cystic fibrosis bronchiectasisSystem Organ Class: 100000004855BronchiectasisEUCTR2019-002840-26-DEovartis Pharma AG72